StockData
Precision BioSciences Inc logo

Precision BioSciences Inc (DTIL) stock

DTILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends May 21
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/3060% above fair value
$7.05−0.23 (-3.16%)

Close on Nov 17, 2026Market cap $194.59MP/E –Yield –

Precision BioSciences enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Precision BioSciences's enterprise value was $154.32M on Nov 11, 2026, against $20.86M a year earlier. Over the last 5 years it ranged from -$105.95M to $284.18M, with a median of -$39.64M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$154.32M+2761.0%
2025Dec 31, 2025$5.39M–
2024Dec 31, 2024-$72.70M–
2023Dec 29, 2023-$80.00M–
2022Dec 30, 2022-$80.03M-128.2%
2021Dec 31, 2021$284.18M-14.8%
2020Dec 31, 2020$333.54M-33.0%
2019Dec 31, 2019$497.47M–

More Precision BioSciences figures

See a number that looks wrong?